A high-profile opioid trial was set to start today in Ohio, but now four companies have inked settlements to avoid trial.
A bellwether trial for thousands of opioid lawsuits is set to begin today. With settlement talks swirling, will the trial end before it begins?
Bloomberg reports that three drug-distribution giants have pitched a $10 billion settlement with state attorneys general, but the AGs want far more.
For just the second time, the DOJ indicted an opioid distributor for its role in illegally pushing pills at the height of the addiction epidemic.
The Justice Department has filed felony criminal charges against a New York pharmaceutical distributor and two of its executives.
It turns out it's not a good idea to kill the messenger, so to speak. As AmerisourceBergen found out, it can become an $885 million hit.
Drugmakers haven't been able to reach a settlement with the cities and counties suing them over the opioid epidemic.
Hundreds of cities and counties have sued to hold opioid makers accountable for the addiction epidemic. Now the feds are getting involved.
Pharmacy giant Walgreens Boots Alliance, which already owns a quarter of drug wholesaler AmerisourceBergen, may want it all.
AmerisourceBergen has received a grand jury subpoena to supply info to the DOJ about its testing of a syringe made at its PharMEDium lab in Tennessee.